Fortress Biotech, Inc. Common Stock (NASDAQ: FBIO) last traded at $2.14, up 2.15% on the session. The quote above updates while this page is open; the figures below are drawn from Fortress Biotech, Inc. Common Stock’s own filings and are restated only when a new one is published.
Fortress Biotech, Inc. Common Stock trades on NASDAQ under the ticker FBIO. Its market capitalisation is $71.12 million.
Valuation measures for Fortress Biotech, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $71.12M |
|---|---|
| Enterprise value | -$14.83M |
| P/E ratio | 0.79 |
| Price / sales | 1.04 |
| Price / book | 0.43 |
| Beta | 1.22 |
Trailing-twelve-month figures tagged in Fortress Biotech, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $68.47M |
|---|---|
| Net income (TTM) | $111.82M |
| EPS (TTM) | $2.70 |
| Gross margin | 65.59% |
| Operating margin | -42.61% |
| Return on equity | 68.12% |
| Cash | $196.58M |
Range and volume for FBIO over the past 52 weeks.
| 52-week high | $4.53 |
|---|---|
| 52-week low | $2.00 |
| Volume | 186.2K |
| Average volume | 490.3K |
| Previous close | $2.09 |
Invest a chosen dollar amount in Fortress Biotech, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell FBIO.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.